| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |